# A cost-utility analysis of interferon beta for multiple sclerosis.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-cost-utility-analysis-of-interferon-beta-for-multiple-sclerosis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Parkin,Paul McNamee,Ann Jacoby,Paul Miller,Simu K. Thomas,David Bates |
| Citations | 69 |
| Fields | Medicine,Social Sciences |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2432640161 |
| PMID | 9580870 |
| Type | article |
| Year | 1998 |

## Paper authors

- [Simu K. Thomas](https://scholariq.org/researchers/simu-k-thomas/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy/)

## Paper topics

- [Vaccine Coverage and Hesitancy](https://scholariq.org/topics/vaccine-coverage-and-hesitancy/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.